Live from the NIH registry
Studies recruiting near Toledo right now
Top 25 of 212 recruiting studies, sorted by proximity — each links to its official registry page
A Study Evaluating the Real World Experience of Participants Treated With BRIUMVI® (Ublituximab-xiiy) for Relapsing Multiple Sclerosis (RMS)
Relapsing Multiple Sclerosis, Multiple Sclerosis
N/A
Observational 2,000 participants sought
TG Therapeutics Investigational Trial Site — Toledo, Ohio (1.4 mi)
· Sponsor: TG Therapeutics, Inc.
Lenalidomide, and Dexamethasone With or Without Daratumumab in Treating Patients With High-Risk Smoldering Myeloma
Smoldering Plasma Cell Myeloma
Phase 3
Interventional 288 participants sought
Mercy Health - Saint Vincent Hospital — Toledo, Ohio (1.4 mi)
· Sponsor: ECOG-ACRIN Cancer Research Group
Comparing the Outcome of Immunotherapy-Based Drug Combination Therapy With or Without Surgery to Remove the Kidney in Metastatic Kidney Cancer, the PROBE Trial
Metastatic Clear Cell Renal Cell Carcinoma, Metastatic Renal Cell Carcinoma
Phase 3
Interventional 364 participants sought
University of Toledo — Toledo, Ohio (1.4 mi)
· Sponsor: SWOG Cancer Research Network
A Phase 1 Study of NRM-823 in Participants With Locally Advanced or Metastatic Refractory Solid Tumors
HNSCC, ESCC
Phase 1
Interventional 150 participants sought
Normunity Investigational Site — Maumee, Ohio (7.9 mi)
· Sponsor: Normunity AccelCo, Inc.
Testing the Impact of an Anti-Cancer Drug, Atezolizumab, After Surgery to Prevent Early Stage Non-small Cell Lung Cancer From Returning, AASI-NSCLC Trial
Lung Non-Small Cell Carcinoma
Phase 3
Interventional 336 participants sought
ProMedica Flower Hospital — Sylvania, Ohio (7.7 mi)
· Sponsor: National Cancer Institute (NCI)
Stepped Approach to Reducing Risk of Suicide in Primary Care
Suicidal Ideation, Suicide, Attempted
N/A
Interventional 2,572 participants sought
Franklin Avenue Primary Care Center — Toledo, Ohio (1.4 mi)
· Sponsor: Cynthia Fontanella
Study of Daraxonrasib (RMC-6236) in Patients With RAS Mutated NSCLC (RASolve 301)
NSCLC (Non-small Cell Lung Cancer), Non-Small Cell Lung Cancer
Phase 3
Interventional 590 participants sought
Taylor Cancer Research Center — Maumee, Ohio (7.9 mi)
· Sponsor: Revolution Medicines, Inc.
A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate to Severe Chronic Obstructive Pulmonary Disease
Moderate to Severe Chronic Obstructive Pulmonary Disease
Phase 2, Phase 3
Interventional 1,156 participants sought
Toledo Institute of Clinical Research Inc. — Toledo, Ohio (1.4 mi)
· Sponsor: Pfizer
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
Breast Cancer
Phase 3
Interventional 3,960 participants sought
ProMedica Toledo Hospital/Russell J Ebeid Children's Hospital — Toledo, Ohio (1.4 mi)
· Sponsor: NRG Oncology
ARTEMIS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With a Heart Attack
Cardiovascular Risk, Acute Myocardial Infarction (AMI)
Phase 3
Interventional 10,000 participants sought
ProMedica — Toledo, Ohio (1.4 mi)
· Sponsor: Novo Nordisk A/S
A Randomized, Double-Blind, Placebo-Controlled Trial on Efficacy and Safety of Fluticasone Propionate/Albuterol Sulfate Combination in Participants 12 Years and Older With Asthma
Asthma
Phase 3
Interventional 724 participants sought
Teva Investigational Site 12063 — Toledo, Ohio (1.4 mi)
· Sponsor: Teva Branded Pharmaceutical Products R&D LLC
Alleviant ALLAY-HFrEF Study
Heart Failure
N/A
Interventional 350 participants sought
ProMedica Toledo Hospital — Toledo, Ohio (1.4 mi)
· Sponsor: Alleviant Medical, Inc.
Testing the Addition of MEDI4736 (Durvalumab) to Chemotherapy Before Surgery for Patients With High-Grade Upper Urinary Tract Cancer
Renal Pelvis and Ureter Urothelial Carcinoma
Phase 2, Phase 3
Interventional 131 participants sought
ProMedica Flower Hospital — Sylvania, Ohio (7.7 mi)
· Sponsor: National Cancer Institute (NCI)
A Study of Treatment for Medulloblastoma Using Sodium Thiosulfate to Reduce Hearing Loss
Childhood Medulloblastoma
Phase 3
Interventional 225 participants sought
ProMedica Toledo Hospital/Russell J Ebeid Children's Hospital — Toledo, Ohio (1.4 mi)
· Sponsor: Children's Oncology Group
Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin
Heart Failure
Phase 3
Interventional 11,300 participants sought
Research Site — Toledo, Ohio (1.4 mi)
· Sponsor: AstraZeneca
Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy Products
Arrhythmia, Bradycardia
N/A
Observational 20,000 participants sought
Research site — Toledo, Ohio (1.4 mi)
· Sponsor: Medtronic
Testing Early Treatment for Patients With High-Risk Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SLL), EVOLVE CLL/SLL Study
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma
Phase 3
Interventional 247 participants sought
Mercy Health - Saint Vincent Hospital — Toledo, Ohio (1.4 mi)
· Sponsor: National Cancer Institute (NCI)
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia
Phase 1, Phase 2
Interventional 960 participants sought
ProMedica Toledo Hospital/Russell J Ebeid Children's Hospital — Toledo, Ohio (1.4 mi)
· Sponsor: PedAL BCU, LLC
Pan-tumor MRD Study
Muscle Invasive Bladder Urothelial Carcinoma, Esophageal Cancer
N/A
Observational 1,350 participants sought
Taylor Cancer Research Center — Maumee, Ohio (7.9 mi)
· Sponsor: Paradigm Health
TTX-080 HLA-G Antagonist in Subjects With Advanced Cancers
Cancer
Phase 1
Interventional 240 participants sought
The University of Toledo — Toledo, Ohio (1.4 mi)
· Sponsor: Tizona Therapeutics, Inc
VE303 for Prevention of Recurrent Clostridioides Difficile Infection
Clostridium Difficile, Clostridium Difficile Infections
Phase 3
Interventional 852 participants sought
Toledo Institute of Clinical Research — Toledo, Ohio (1.4 mi)
· Sponsor: Vedanta Biosciences, Inc.
A Long-term Extension Study of Dazodalibep in Participants With Sjögren's Syndrome (SS)
Sjögren's Syndrome
Phase 3
Interventional 844 participants sought
University of Toledo Medical Center — Toledo, Ohio (1.4 mi)
· Sponsor: Amgen
A Study to Investigate Outcomes With Elecoglipron Compared With Placebo in Adult Participants With Chronic Kidney Disease.
Chronic Kidney Disease
Phase 3
Interventional 7,000 participants sought
Research Site — Maumee, Ohio (7.9 mi)
· Sponsor: AstraZeneca
Efficacy & Safety of Olvi-Vec and Platinum-doublet + Bevacizumab Compared to Physician's Choice of Chemotherapy and Bevacizumab in Platinum-Resistant/Refractory Ovarian Cancer (PRROC) (OnPrime, GOG-3076)
Platinum-resistant Ovarian Cancer, Platinum-refractory Ovarian Cancer
Phase 3
Interventional 186 participants sought
ProMedica Flower Hospital — Sylvania, Ohio (7.7 mi)
· Sponsor: Genelux Corporation
A Study to Test the Addition of the Drug Cabozantinib to Chemotherapy in Patients With Newly Diagnosed Osteosarcoma
High Grade Osteosarcoma, Localized Osteosarcoma
Phase 2, Phase 3
Interventional 1,122 participants sought
ProMedica Toledo Hospital/Russell J Ebeid Children's Hospital — Toledo, Ohio (1.4 mi)
· Sponsor: National Cancer Institute (NCI)